Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study
Jean Regina(University of Lausanne), Loïc Lhopitallier(University of Lausanne), Benjamin Viala(University of Lausanne), Mehdi Belkoniene(University of Lausanne), Marie‐Annick Le Pogam(Centre universitaire de médecine générale et santé publique, Lausanne), Paraskevas Filippidis(Yale University), Tapio Niemi(Centre universitaire de médecine générale et santé publique, Lausanne), David Haefliger(University of Lausanne), Antonios Kritikos(University of Lausanne), Jean‐Luc Pagani(University of Lausanne), Oriol Manuel(University of Lausanne), Matthaios Papadimitriou‐Olivgeris(University Hospital of Lausanne), Jonathan Tschopp(University of Lausanne), Florian Desgranges(University of Lausanne), Katia Jaton(University of Lausanne), Raphaël Burger(University of Lausanne), Eleftheria Kampouri(University of Lausanne), Carlos Fidalgo(University of Lausanne), Pierre‐Alexandre Bart(University of Lausanne), Laurence Rochat(University of Lausanne), Laurence Senn(University of Lausanne)
Cited by 64
Related Papers
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
|Clinical Infectious Diseases|2012|299
Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum
|Clinical Infectious Diseases|2024|145
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study
|American Journal of Transplantation|2020|134
Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission
|Journal of Antimicrobial Chemotherapy|2012|114